Laya

OGD clinical indicators

Surveillance

Code Letter Desc
(0026) Barrett's mucosa shorter than 3cm, without dysplasia on a previous endoscopy: benefit is for a surveillance endoscopy every 3 years
(0027) Barrett's mucosa, greater than 3cm, without dysplasia on a previous endoscopy: benefit is for a surveillance endoscopy every 2 years
(0028) Barrett's mucosa, with low-grade dysplasia on a previous endoscopy: benefit is for a surveillance endoscopy every 6 months until 2 consecutive endoscopies have no metaplasia
(0029) Barrett's mucosa, with high-grade dysplasia on a previous endoscopy: benefit is for a surveillance endoscopyevery 3 months
(0030) Gastric intestinal metaplasia/gastric epithelial dysplasia/atrophic gastritis with low-grade dysplasia: benefit is for a surveillance endoscopy every 3 years
(0031) Gastric intestinal metaplasia/gastric epithelial dysplasia/atrophic gastritis with high-grade dysplasia: benefit is for a surveillance endoscopy at 6 months
(0032) Upper GI surveillance for members with Peutz-Jeghers syndrome: benefit is for a surveillance endoscopy every 2 years from age 18 years
(0033) upper gi surveillance for members with juvenile polyposis: benefit is for a surveillance endoscopy every 3 years from age 18 years
(0034) Upper GI surveillance for members with Lynch Syndrome: benefit is for surveillance endoscopy every 2 years from age 50 years
(0035) Upper GI surveillance for members with MUTYH bi-allelic carriers: benefit will be provided for a 3 yearly gastrointestinal endoscopy from age 30 years